Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

ER Y537N

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

ER amplification (1)

ER amplification (1)

›

ER Y537N	HER2 Negative Breast Cancer	ER Y537N	HER2 Negative Breast Cancer	SAR439859 Sensitive: C3 – Early Trials SAR439859 Sensitive : C3	SAR439859 Sensitive: C3 – Early Trials SAR439859 Sensitive : C3
ER Y537N	Breast Cancer	ER Y537N	Breast Cancer	tamoxifen + fulvestrant Sensitive: C4 – Case Studies tamoxifen + fulvestrant Sensitive : C4	tamoxifen + fulvestrant Sensitive: C4 – Case Studies tamoxifen + fulvestrant Sensitive : C4
ER Y537N	Hormone Receptor Positive Breast Cancer	ER Y537N	Hormone Receptor Positive Breast Cancer	abemaciclib Sensitive: C4 – Case Studies abemaciclib Sensitive : C4	abemaciclib Sensitive: C4 – Case Studies abemaciclib Sensitive : C4
ER Y537N	Hormone Receptor Positive Breast Cancer	ER Y537N	Hormone Receptor Positive Breast Cancer	palbociclib Resistant: C4 – Case Studies palbociclib Resistant : C4	palbociclib Resistant: C4 – Case Studies palbociclib Resistant : C4
ER Y537N	Ovarian Serous Adenocarcinoma	ER Y537N	Ovarian Serous Adenocarcinoma	fulvestrant Sensitive: C4 – Case Studies fulvestrant Sensitive : C4	fulvestrant Sensitive: C4 – Case Studies fulvestrant Sensitive : C4